This inventor holds 1 USPTO granted patent. Top assignee: Basilea Pharmaceutica Ag. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Marco Alpegiani, Jr: Innovator in Antibiotic Development
Introduction
Marco Alpegiani, Jr. is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotics. His innovative work has led to the creation of a patent that plays a crucial role in the medical industry.
Latest Patents
Marco Alpegiani, Jr. holds a patent for a compound titled "Crystalline (6R,7R)-7-{2-(5-amino-[1,2,4] thiadiazol-3-yl)-2-[(Z)-trityloxyimino]-acetylamino}-3-[(R)-1'-tert-butoxycarbonyl-2-oxo-[1,3′]bipyrrolidinyl-(3E)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester." This patent describes a solid DMSO solvate of a compound that serves as a useful intermediate for preparing the broad-spectrum antibiotics Ceftobiprole and Ceftobiprole Medocaril. He has 1 patent to his name.
Career Highlights
Marco is currently employed at Basilea Pharmaceutica AG, where he continues to work on innovative solutions in the pharmaceutical sector. His expertise and dedication have made him a valuable asset to the company.
Collaborations
Throughout his career, Marco has collaborated with esteemed colleagues such as Michael Schleimer and Markus Heubes. These partnerships have fostered an environment of innovation and creativity in their projects.
Conclusion
Marco Alpegiani, Jr. is a distinguished inventor whose work in antibiotic development has made a significant impact in the medical field. His contributions continue to advance pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile